China Grand Pharmaceutical and Healthcare Holdings Ltd (0512:HK) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the China Grand Pharmaceutical and Healthcare Holdings Ltd stock forecast from 0 analysts, the average analyst target price for China Grand Pharmaceutical and Healthcare Holdings Ltd is not available over the next 12 months. China Grand Pharmaceutical and Healthcare Holdings Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of China Grand Pharmaceutical and Healthcare Holdings Ltd is Slightly Bullish , which is based on 6 positive signals and 4 negative signals. At the last closing, China Grand Pharmaceutical and Healthcare Holdings Ltd’s stock price was HKD 3.99. China Grand Pharmaceutical and Healthcare Holdings Ltd’s stock price has changed by +0.50% over the past week, -1.48% over the past month and -19.07% over the last year.
No recent analyst target price found for China Grand Pharmaceutical and Healthcare Holdings Ltd
No recent average analyst rating found for China Grand Pharmaceutical and Healthcare Holdings Ltd
Company Overview China Grand Pharmaceutical and Healthcare Holdings Ltd
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It also manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additives; disposal surgical products; and Chinese medicine and health food products, as well as engages in the treatment of sewage. Grand Pharmaceutical Group Limited has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited. Grand Pharmaceutical Group Limited was incorporated in 1995 and is based in Central, Hong Kong. Address: The Center, Central, Hong Kong Read Less
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respir...Read More
Frequently Asked Questions About China Grand Pharmaceutical and Healthcare Holdings Ltd (0512:HK) Stock
Stock Target Advisor's fundamental analysis for China Grand Pharmaceutical and Healthcare Holdings Ltd's stock is Slightly Bullish .
0512:HK stock's dividend yield is 3.51%.
Our analysis grades 0512:HK stock's dividend yield at F. This means that 0512:HK stock's dividend yield is above 41% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the HK exchange.
Based on this 0512:HK may be a average dividend stock for its sector.
Unfortunately we do not have enough data on 0512:HK's stock to indicate what its average analyst target is.
0512:HK stock's Price/Earning ratio is 7.39.
Our analysis grades 0512:HK stock's Price / Earning ratio at D+. This means that 0512:HK stock's Price/Earning ratio is above 32.99999999999999% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the HK exchange.
Based on this 0512:HK may be fairly valued for its sector
The last closing price of 0512:HK's stock was HKD 3.99.
The most recent market capitalization for 0512:HK is HKD 13.97B.
Unfortunately we do not have enough analyst data on 0512:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains China Grand Pharmaceutical and Healthcare Holdings Ltd's stock.
As per our most recent records China Grand Pharmaceutical and Healthcare Holdings Ltd has 10,534 Employees.
China Grand Pharmaceutical and Healthcare Holdings Ltd's registered address is The Center, Central, Hong Kong.
You can get more information about it from China Grand Pharmaceutical and Healthcare Holdings Ltd's website at https://www.grandpharm.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0512:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
